Swissmedic has granted a temporary authorization for the distribution of Enrylaze 10 mg/vial injection solution in…
Category: Switzerland
Switzerland updates on medical device regulation and quality.
Swissmedic Issues Recall of Locametz 25 mcg Multidose Kits for Radiopharmaceutical Use
Swissmedic has announced a precautionary recall of specific batches of Locametz 25 mcg Multidose Kits for…
Swissmedic Expands Therapeutic Indication for Ryeqo®
On 17 December 2025, Swissmedic announced an important regulatory update concerning the medication Ryeqo®. The approval…
Swissmedic Approves Temporary Distribution of Hibidil Sterile Solution in French Packaging
On December 17, 2025, Swissmedic approved a temporary measure allowing the distribution of Hibidil sterile solution…
Swissmedic Announces Therapeutic Expansion for Blenrep®: Key Updates for Regulatory Teams
On December 13, 2025, Swissmedic announced the extension of the therapeutic indication for Blenrep®, signaling a…
Swissmedic Alerts on Compromised Originality Seals for Urapidil Stragen i.v. – Critical Notice for Healthcare Providers
On December 12, 2025, Swissmedic issued an important notice regarding compromised originality seals on specific packaging…
Swissmedic Announces Appointment of Two New Members to Agency Council for 2026–2029 Term
On December 12, 2025, Swissmedic announced the addition of two new members to its Agency Council,…
Swissmedic Announcement: Expanded Indication for Sarclisa®
Swissmedic has issued an important update for healthcare and regulatory professionals regarding Sarclisa®. An extension of…
Swissmedic Launches 2025 Oversight Fee Self-Declaration: Key Details for Medical Device Professionals
Swissmedic, Switzerland’s authority for therapeutic products, has announced the self-declaration deadline for the 2025 oversight fee.…
Swissmedic Expands Therapeutic Indication for Jemperli®
On December 5, 2025, Swissmedic announced an extension to the therapeutic indication for Jemperli®, emphasizing its…